[1] Thomas M,Langley B,Berry C,et al.Myostatin,a negative regulator of muscle growth,functions by inhibiting myoblast proliferation [J].J Biol Chem,2000,275(51):40235-40243.
[2] Buckingham M,Tajbakhsh S.Expression of MyoGenic factors in the mouse:myf-5,the first member of the MyoD gene family to be transcribed during skeletal MyoGenesis [J].C R Acad Sci Ser III,1993,316(9): 1032-1046.
[3] Lassar A B,Skapek S X,Novitch B.Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal [J].Curr Opin Cell Biol,1994,6(6):788-794.
[4] Miyake M,Hayashi S,Iwasaki S,et al.TIEG1 negatively controls the myoblast pool indispensable for fusion during MyoGenic differentiation of C2C12 cells[J].J Cell Physiol,2011,226(4):1128-1136.
[5] Muscat G E,Rea S,Downes M.Identification of a regulatory function for an orphan receptor in muscle:COUP-TF II affects the expression of the MyoD gene family during MyoGenesis [J].Nucleic Acids Res,1995,23(8):1311-1318.
[6] Davis RL,Weintraub H,Lassar A B.Expression of a single transfected cDNA converts fibroblasts to myoblasts [J].Cell,1987,51(6):987-1000.
[7] Wyzykowski J C,Winata T I,Mitin N,et al.Identification of novel MyoD gene targets in proliferating myogenic stem cells [J].Mol Cell Biol,2002,22(17): 6199-6208.
[8] Wright W E,Sassoon D A, Lin V K.MyoGenin,a factor regulating myogenesis,has a domain homologous to MyoD [J].Cell,1989,56(4):607-617.
[9] Weintraub H,Davis R,Tapscott S,et al.The MyoD gene family:Nodal point during specification of the muscle cell lineage [J].Science,1991,251(4995): 761-766.
[10] Ott M O,Bober E,Lyons G,et al.Early expression of the myogenic regulatory gene,myf-5, in precursor cells of skeletal muscle in the mouse embryo [J]. Development,1991,111(4):1097-1107.
[11] Gartel A L,Radhakrishnan S K.Lost in transcription: P21 repression, mechanisms,and consequences [J]. Cancer Res,2005,65(10):3980-3985.
[12] Spiller M P,Kambadur R,Jeanplong F,et al.The myostatin gene is a downstream target gene of basic helix-loop-helix transcription factor MyoD [J].Mol Cell Biol,2002,22(20):7066-7082.
[13] Tsuchida K,Arai K Y,Kuramoto Y,et al.Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family[J].J Biol Chem,2000,275(52):40788-40796.
[14] Hill J J,Qiu Y,Hewick R M, et al.Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1:A novel protein with protease inhibitor and follistatin domains[J]. Mol Endocrinol,2003,17(6):1144-1154.
[15] Szlama G,Kondas K,Trexler M,et al.WFIKKN1 and WFIKKN2 bind growth factors TGFbeta1, BMP2 and BMP4 but do not inhibit their signalling activity[J].FEBS J, 2010,277(24):5040-5050.
[16] Haidet A M,Rizo L,Handy C,et al. Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors[J]. Proc Natl Acad Sci USA,2008,105(11):4318-4322.
[17] Monestier O,Brun C,Heu K,et al.Ubiquitous Gasp1 overexpression in mice leads mainly to a hypermuscular phenotype[J].BMC Genomics,2012,13: 541.
[18] Barberi L,Dobrowolny G,Pelosi L,et al. Muscle involvement and IGF-1 signaling in genetic disorders:New therapeutic approaches[J].Endocr Dev,2009, 14: 29-37.
[19] Guardiola O,Lafuste P,Brunelli S,et al.Cripto regulates skeletal muscle regeneration and modulates satellite cell determination by antagonizing myostatin[J].Proc Natl Acad Sci U S A,2012,109(47): 3231-3240.
[20] Minetti G C, Colussi C, Adami R, et al. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors[J]. Nat Med, 2006,12:1147-1150.
[21] Kota J, Handy CR, Haidet AM, et al. Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates[J]. Sci Transl Med,2009,1:6-15.
[22] Haidet A M, Rizo L, Handy C, et al. Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors[J]. Proc Natl Acad Sci USA,2008,105:4318-4322.
[23] Lee S J, McPherron A C. Regulation of myostatin activity and muscle growth[J]. Proc Natl Acad Sci USA,2001,98:9306-9311.
[24] Tsuchida K, Arai K Y, Kuramoto Y, et al. Identification and characterization of a novel follistatin -like protein as a binding protein for the TGF-beta family[J]. J Biol Chem, 2000,275:40788-40796.
[25] Hill JJ, Qiu Y, Hewick RM, Wolfman NM. Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: A novel protein with protease inhibitor and follistatin domains[J]. Mol Endocrinol,2003,17:1144-1154.
[26] Kondás K, Szláma G, Trexler M, et al. Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11[J]. J Biol Chem, 2008,283:23677-23684.
[27] Trexler M, Bányai L, Patthy L. Distinct expression pattern of two related human proteins containing multiple types of protease-inhibitory modules[J]. Biol Chem, 2002,383:223-228.
[28] Sarkar A,Sim C,Hong Y S,et a1.Molecular evolutionary analysis of the widespread piggyBac transposon family and related “domesticated” sequences [J].Mol Genet Genom,2003,270 (2):173 -180.
[29] Calos M P. The phiC31 integrase system for gene therapy [J].Curr Gene Ther,2006,6(6): 633-645.
[30] Olson E N,Brennan T J,Chakraborty T,et al.Molecular control of myogenesis: antagonism between growth and differentiation[J].Mol Cell Biochem,1991,104(1/2):7-13.
